Depression Awareness Monthly
0
  • Home
  • Latest News
  • Depression
Depression Awareness Monthly
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression
Latest News

Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes

Doctorslounge
Posted by Doctorslounge
Share on
READ NEXT
Pupillary Light Reflex Can Predict Improvement With rTMS in Depression

More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone

Read More

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Doctorslounge
Previous Article Men Face Five to Seven Times Higher Rates of Firearm Deaths Than Women
Next Article Final Exams Don’t Have to Be High Stress for Your Teen

ADVERTISEMENT

ADVERTISEMENT

You Might Also Enjoy

Latest News

People With Eating Disorders Report Success Self-Medicating With Non-Rx Drugs

Latest News

Preemies’ Early-Life Medical Risk Tied to Worse Health at Age 35

Latest News

Magnesium-Ibogaine May Be Beneficial for Combat Veterans With TBI

Latest News

Teen Tobacco Product Use Tied to Worse Mental Health

Load More
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression

© 2020 - 2021 Powered by eHealthcare Solutions | Privacy Policy

×